Search - tctmd.com

Displaying 1 - 20 of 182

Sort: Relevancy | Date

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Daily News

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Todd Neale

October 16, 2023

News Conference News EACTS 2023

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Michael O'Riordan

October 11, 2023

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Daily News

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Caitlin E. Cox

October 25, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Conference News EuroPCR 2022

Fibromuscular Dysplasia in SCAD Tied to Worse Long-term Prognosis

Caitlin E. Cox

May 19, 2022

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

News Daily News

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

L.A. McKeown

November 04, 2021

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

News Conference News ESC 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Michael O'Riordan

August 30, 2021

News Features

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Yael L. Maxwell

August 26, 2021

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

Caitlin E. Cox

September 29, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Conference News ISET 2020

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

Caitlin E. Cox

February 05, 2020

Advertisement

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

Fibromuscular Dysplasia in SCAD Tied to Worse Long-term Prognosis

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

More Insights Into AAA Genetics Spur New Questions on Screening

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content